Arvinas, Inc. (ARVN)

NASDAQ: ARVN · Real-Time Price · USD

11.82

+0.38 (3.32%)

At close: Feb 18, 2026, 4:00 PM EST

12.00

+0.18 (1.52%)

After-hours: Feb 18, 2026, 6:14 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	263.40M	78.50M	131.40M	53.60M	25.90M
Pharmaceuticals Growth	235.54%	-40.26%	145.15%	106.95%	-39.77%
Total	263.40M	78.50M	131.40M	53.60M	25.90M
Total Growth	235.54%	-40.26%	145.15%	106.95%	-39.77%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	263.40M	78.50M	131.40M	53.60M	25.90M
United States Growth	235.54%	-40.26%	145.15%	106.95%	-39.77%
Total	263.40M	78.50M	131.40M	53.60M	25.90M
Total Growth	235.54%	-40.26%	145.15%	106.95%	-39.77%

Source: S&P Global Market Intelligence.